106 related articles for article (PubMed ID: 2984802)
1. Effect of a fibrin(ogen)-derived vasoactive peptide on polymorphonuclear leukocyte emigration.
Saldeen K; Christie N; Nelson WR; Movat HZ
Thromb Res; 1985 Jan; 37(1):85-9. PubMed ID: 2984802
[TBL] [Abstract][Full Text] [Related]
2. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
Movat HZ; Rettl C; Burrowes CE; Johnston MG
Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
[TBL] [Abstract][Full Text] [Related]
3. Tissue differences in vascular permeability induced by leukotriene B4 and prostaglandin E2 in the rat.
Stenson WF; Chang K; Williamson JR
Prostaglandins; 1986 Jul; 32(1):5-17. PubMed ID: 3020620
[TBL] [Abstract][Full Text] [Related]
4. Isomers of leukotriene B4 possess different biological potencies.
Ford-Hutchinson AW; Bray MA; Cunningham FM; Davidson EM; Smith MJ
Prostaglandins; 1981 Jan; 21(1):143-52. PubMed ID: 6259698
[TBL] [Abstract][Full Text] [Related]
5. Effect of vasoactive agents on polymorphonuclear leukocyte emigration in vivo.
Issekutz AC
Lab Invest; 1981 Sep; 45(3):234-40. PubMed ID: 6944561
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes.
Levine JD; Lau W; Kwiat G; Goetzl EJ
Science; 1984 Aug; 225(4663):743-5. PubMed ID: 6087456
[TBL] [Abstract][Full Text] [Related]
7. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
Sueishi K; Nanno S; Tanaka K
Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
[TBL] [Abstract][Full Text] [Related]
8. The effect of vasodilator prostaglandins on polymorphonuclear leukocyte infiltration and vascular injury.
Issekutz AC; Movat HZ
Am J Pathol; 1982 Jun; 107(3):300-9. PubMed ID: 6952768
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B4: a mediator of vascular permeability.
Bray MA; Cunningham FM; Ford-Hutchinson AW; Smith MJ
Br J Pharmacol; 1981 Mar; 72(3):483-6. PubMed ID: 6266567
[TBL] [Abstract][Full Text] [Related]
10. Influence of arachidonic acid metabolites in vitro and in uterine washings on migration of equine neutrophils under agarose.
Watson ED; Stokes CR; Bourne FJ
Res Vet Sci; 1987 Sep; 43(2):203-7. PubMed ID: 2825309
[TBL] [Abstract][Full Text] [Related]
11. Further studies on biological activities of new peptide fragments derived from high molecular weight kininogen: an enhancement of the vascular permeability increase of the fragments by prostaglandin E2.
Oh-ishi S; Tanaka K; Katori M; Han YN
Life Sci; 1977 Feb; 20(4):695-9. PubMed ID: 839984
[No Abstract] [Full Text] [Related]
12. Leukotrienes as mediators of skin inflammation.
Ford-Hutchinson AW; Rackman A
Br J Dermatol; 1983 Jul; 109 Suppl 25():26-9. PubMed ID: 6305389
[No Abstract] [Full Text] [Related]
13. Effect of leukotriene B4, prostaglandin E2 and arachidonic acid on cytosolic-free calcium in human neutrophils.
Lew PD; Dayer JM; Wollheim CB; Pozzan T
FEBS Lett; 1984 Jan; 166(1):44-8. PubMed ID: 6319189
[TBL] [Abstract][Full Text] [Related]
14. Eicosanoids and equine leucocyte locomotion in vitro.
Lees P; Dawson J; Sedgwick AD
Equine Vet J; 1986 Nov; 18(6):493-7. PubMed ID: 3026799
[No Abstract] [Full Text] [Related]
15. Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.
Spada CS; Woodward DF; Hawley SB; Nieves AL; Williams LS; Feldmann BJ
Am J Pathol; 1988 Feb; 130(2):354-68. PubMed ID: 2829632
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.
Brain SD; Williams TJ
Br J Pharmacol; 1985 Dec; 86(4):855-60. PubMed ID: 2416378
[TBL] [Abstract][Full Text] [Related]
17. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
Kessler CM; Bell WR
J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent differential development of leukotactic and vasoactive responsiveness to acute inflammatory mediators.
Angle MJ; McManus LM; Pinckard RN
Lab Invest; 1986 Dec; 55(6):616-21. PubMed ID: 3465972
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.
Ham EA; Soderman DD; Zanetti ME; Dougherty HW; McCauley E; Kuehl FA
Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4349-53. PubMed ID: 6308617
[TBL] [Abstract][Full Text] [Related]
20. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth.
Akakura N; Hoogland C; Takada YK; Saegusa J; Ye X; Liu FT; Cheung AT; Takada Y
Cancer Res; 2006 Oct; 66(19):9691-7. PubMed ID: 17018627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
